rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2009-12-4
|
pubmed:abstractText |
Poorly differentiated carcinomas represent an aggressive group of thyroid tumors with controversial classification placement and poorly understood pathogenesis. Molecular data in this group of tumors are extremely heterogeneous, possibly reflecting different inclusion criteria. Recently homogeneous diagnostic criteria have been proposed by our group (Turin proposal) that need to be complemented by detailed molecular characterization.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1945-7197
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4735-41
|
pubmed:meshHeading |
pubmed-meshheading:19837916-Adult,
pubmed-meshheading:19837916-DNA,
pubmed-meshheading:19837916-Female,
pubmed-meshheading:19837916-Gene Rearrangement,
pubmed-meshheading:19837916-Genes, ras,
pubmed-meshheading:19837916-Humans,
pubmed-meshheading:19837916-Immunohistochemistry,
pubmed-meshheading:19837916-Male,
pubmed-meshheading:19837916-Middle Aged,
pubmed-meshheading:19837916-Mutation,
pubmed-meshheading:19837916-Point Mutation,
pubmed-meshheading:19837916-Prognosis,
pubmed-meshheading:19837916-Renin-Angiotensin System,
pubmed-meshheading:19837916-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19837916-Survival,
pubmed-meshheading:19837916-Survival Analysis,
pubmed-meshheading:19837916-Thyroid Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.
|
pubmed:affiliation |
Department of Clinical and Biological Sciences, San Luigi Hospital, 10043 Orbassano, Italy. marco.volante@unito.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|